Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1192/bjp.188.1.46.
Affiliations
- PMID: 16388069
- DOI: 10.1192/bjp.188.1.46
Randomized Controlled Trial
Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study
Sophia Frangou et al. Br J Psychiatry. 2006 Jan.
Abstract
Background: Epidemiological and clinical studies suggest that increased intake of eicosapentaenoic acid (EPA) alleviates unipolar depression.
Aims: To examine the efficacy of EPA in treating depression in bipolar disorder.
Method: In a12-week, double-blind study individuals with bipolar depression were randomly assigned to adjunctive treatment with placebo (n=26) or with 1 g/day (n=24) or 2 g/day (n=25) of ethyl-EPA. Primary efficacy was assessed by the Hamilton Rating Scale for Depression (HRSD), with changes in the Young Mania Rating Scale and Clinical Global Impression Scale (CGI) as secondary outcome measures.
Results: There was no apparent benefit of 2 g over 1 g ethyl-EPA daily. Significant improvement was noted with ethyl-EPA treatment compared with placebo in the HRSD (P=0.04) and the CGI (P=0.004) scores. Both doses were well tolerated.
Conclusions: Adjunctive ethyl-EPA is an effective and well-tolerated intervention in bipolar depression.
Comment in
- Ethyl-eicosapentaenoic acid in bipolar depression.
Upton I. Upton I. Br J Psychiatry. 2006 Aug;189:191. doi: 10.1192/bjp.189.2.191. Br J Psychiatry. 2006. PMID: 16880499 No abstract available.
Similar articles
- Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM. Keck PE Jr, et al. Biol Psychiatry. 2006 Nov 1;60(9):1020-2. doi: 10.1016/j.biopsych.2006.03.056. Epub 2006 Jun 30. Biol Psychiatry. 2006. PMID: 16814257 Clinical Trial. - Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
Keck PE Jr, Versiani M, Potkin S, West SA, Giller E, Ice K; Ziprasidone in Mania Study Group. Keck PE Jr, et al. Am J Psychiatry. 2003 Apr;160(4):741-8. doi: 10.1176/appi.ajp.160.4.741. Am J Psychiatry. 2003. PMID: 12668364 Clinical Trial. - A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J. Calabrese JR, et al. Am J Psychiatry. 2005 Jul;162(7):1351-60. doi: 10.1176/appi.ajp.162.7.1351. Am J Psychiatry. 2005. PMID: 15994719 Clinical Trial. - Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA. Houston JP, et al. J Clin Psychiatry. 2009 Nov;70(11):1540-7. doi: 10.4088/JCP.08m04895yel. Epub 2009 Sep 22. J Clin Psychiatry. 2009. PMID: 19778495 Clinical Trial. - Ethyl-EPA in Huntington disease: potentially relevant mechanism of action.
Murck H, Manku M. Murck H, et al. Brain Res Bull. 2007 Apr 30;72(2-3):159-64. doi: 10.1016/j.brainresbull.2006.10.020. Epub 2006 Nov 15. Brain Res Bull. 2007. PMID: 17352940 Review.
Cited by
- Current Insights into the Use of Probiotics and Fatty Acids in Alleviating Depression.
Gao H, He C, Xin S, Hua R, Du Y, Wang B, Gong F, Yu X, Pan L, Gao L, Xu J. Gao H, et al. Microorganisms. 2023 Aug 5;11(8):2018. doi: 10.3390/microorganisms11082018. Microorganisms. 2023. PMID: 37630578 Free PMC article. Review. - Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression.
Shelton RC, Miller AH. Shelton RC, et al. Prog Neurobiol. 2010 Aug;91(4):275-99. doi: 10.1016/j.pneurobio.2010.04.004. Epub 2010 Apr 22. Prog Neurobiol. 2010. PMID: 20417247 Free PMC article. Review. - Brain lipid concentrations in bipolar disorder.
Igarashi M, Ma K, Gao F, Kim HW, Greenstein D, Rapoport SI, Rao JS. Igarashi M, et al. J Psychiatr Res. 2010 Feb;44(3):177-82. doi: 10.1016/j.jpsychires.2009.08.001. Epub 2009 Sep 19. J Psychiatr Res. 2010. PMID: 19767014 Free PMC article. - Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.
Liu JJ, Galfalvy HC, Cooper TB, Oquendo MA, Grunebaum MF, Mann JJ, Sublette ME. Liu JJ, et al. J Clin Psychiatry. 2013 Jul;74(7):732-8. doi: 10.4088/JCP.12m07970. J Clin Psychiatry. 2013. PMID: 23945451 Free PMC article. - Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Yatham LN, et al. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. Bipolar Disord. 2018. PMID: 29536616 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials